--- title: "Imaging Biometrics Corrects AGM Share Sub-division Terms Ahead of June Meeting" type: "News" locale: "en" url: "https://longbridge.com/en/news/286205562.md" description: "Imaging Biometrics Limited has corrected an error regarding its proposed share sub-division ahead of the Annual General Meeting on June 3, 2026. Each ordinary share of £0.01 will now be sub-divided into one ordinary share of £0.005, with the total shares remaining at 246,709,789. The AGM resolutions remain unaffected, and updated documentation will be available on the company’s website. Spark’s AI Analyst rates IBAI stock as Neutral, citing weak financial performance and bearish technicals, despite low leverage reducing balance-sheet risk." datetime: "2026-05-13T06:07:25.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286205562.md) - [en](https://longbridge.com/en/news/286205562.md) - [zh-HK](https://longbridge.com/zh-HK/news/286205562.md) --- # Imaging Biometrics Corrects AGM Share Sub-division Terms Ahead of June Meeting ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks IQ-AI ( (GB:IBAI) ) has provided an update. Imaging Biometrics Limited has corrected an error in its recent notice regarding a proposed share sub-division ahead of its upcoming Annual General Meeting in Jersey on 3 June 2026. The company clarified that each ordinary share of £0.01 will be sub-divided into one ordinary share of £0.005, with the total number of shares in issue remaining unchanged at 246,709,789, and confirmed that all other AGM resolutions are unaffected. The updated AGM documentation, including the corrected notice and proxy form, will be made available on the company’s website for shareholders. While the change is technical in nature and does not alter shareholders’ aggregate holdings, the clarification removes potential confusion around the capital structure as the group continues to develop its neuroimaging software and organ-on-a-chip offerings in global healthcare and research markets. **Spark’s Take on IBAI Stock** According to Spark, TipRanks’ AI Analyst, IBAI is a Neutral. The score is driven primarily by weak financial performance (persistent losses and ongoing cash burn), reinforced by bearish technicals with the stock trading well below key moving averages. Low reported leverage helps reduce balance-sheet risk, but valuation is constrained by negative earnings and no dividend yield data. To see Spark’s full report on IBAI stock, click here. **More about IQ-AI** Imaging Biometrics Limited is an LSE-listed healthcare technology group specialising in quantitative neuroimaging software and organ-on-a-chip technologies. Its main subsidiary, Imaging Biometrics LLC, provides advanced MRI analysis tools for brain tumour assessment, distributed globally through partners including GE HealthCare, while Kirkstall Limited offers the Quasi Vivo organ-on-a-chip platform for pharmaceutical and toxicology research. **Average Trading Volume:** 537,715 **Technical Sentiment Signal:** Strong Sell **Current Market Cap:** £1.42M For an in-depth examination of IBAI stock, go to TipRanks’ Overview page. ### Related Stocks - [516930.CN](https://longbridge.com/en/quote/516930.CN.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [513060.CN](https://longbridge.com/en/quote/513060.CN.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [159837.CN](https://longbridge.com/en/quote/159837.CN.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [512170.CN](https://longbridge.com/en/quote/512170.CN.md) - [159898.CN](https://longbridge.com/en/quote/159898.CN.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [BIS.US](https://longbridge.com/en/quote/BIS.US.md) - [516500.CN](https://longbridge.com/en/quote/516500.CN.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [562600.CN](https://longbridge.com/en/quote/562600.CN.md) - [159883.CN](https://longbridge.com/en/quote/159883.CN.md) - [159849.CN](https://longbridge.com/en/quote/159849.CN.md) - [GEHC.US](https://longbridge.com/en/quote/GEHC.US.md) ## Related News & Research - [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md) - [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md) - [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md) - [Lifeward Delays Quarterly Report Amid Deal Accounting](https://longbridge.com/en/news/286586728.md) - [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)